More articles from Review

You have access
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer
Zhixian Liang, Reilly L. Kidwell, Haijing Deng and Qi Xie

Cancer Biology & Medicine February 2020, 17 (1) 9-19; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0347
You have access
COX-2 as a potential biomarker and therapeutic target in melanoma
Diana Valentina Tudor, Ioana Bâldea, Mihai Lupu, Teodor Kacso, Eniko Kutasi, Andreea Hopârtean, Roland Stretea and Adriana Gabriela Filip

Cancer Biology & Medicine February 2020, 17 (1) 20-31; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0339
You have access
Metabolic reprogramming in triple-negative breast cancer
Zhanyu Wang, Qianjin Jiang and Chenfang Dong

Cancer Biology & Medicine February 2020, 17 (1) 44-59; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0210
You have access
Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment
Yuting Zhang, Liu Guoqiang, Miaomiao Sun and Xin Lu

Cancer Biology & Medicine February 2020, 17 (1) 32-43; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0372
You have access
Technical advances in NK cell-based cellular immunotherapy
Fang Fang, Wei Wang, Minhua Chen, Zhigang Tian and Weihua Xiao

Cancer Biology & Medicine November 2019, 16 (4) 647-654; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0187
You have access
Tobacco, air pollution, environmental carcinogenesis, and thoughts on conquering strategies of lung cancer
Guangbiao Zhou

Cancer Biology & Medicine November 2019, 16 (4) 700-713; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0180
You have access
Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
Guilian Shi, Mingchuan Zhong, Fuli Ye and Xiaoming Zhang

Cancer Biology & Medicine November 2019, 16 (4) 714-728; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0232
You have access
The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?
Yulu Zhou, Yong Shen, Cong Chen, Xinbing Sui, Jingjing Yang, Linbo Wang and Jichun Zhou

Cancer Biology & Medicine November 2019, 16 (4) 630-646; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0158
You have access
The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
Wenxiao Jia, Qianqian Gao, Anqin Han, Hui Zhu and Jinming Yu

Cancer Biology & Medicine November 2019, 16 (4) 655-670; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0144
You have access
Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
Tong Wang, Zhiyong Wang, Ruifang Niu and Liang Wang

Cancer Biology & Medicine November 2019, 16 (4) 671-687; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0228

Main menu

User menu

Search

More articles from Review

Pages

Navigate

More Information

For Authors

Journal Services